Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Iopamidol
Bracco Imaging spa
V08AB; V08AB04
Iopamidol
370 milligram(s)
Solution for injection
Product subject to prescription which may not be renewed (A)
Watersoluble, nephrotropic, low osmolar X-ray contrast media; iopamidol
Marketed
1983-03-10
PACKAGE LEAFLET: INFORMATION FOR THE USER NIOPAM 370 SOLUTION FOR INJECTION (Iopamidol) The name of your medicine is Niopam 370 solution for injection, which will be called Niopam throughout this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet, see section 4. WHAT IS IN THIS LEAFLET : 1. What Niopam is and what it is used for 2. What you need to know before you are given Niopam 3. How you are given Niopam 4. Possible side effects 5. How to store Niopam 6. Contents of the pack and other information 1. WHAT IS NIOPAM AND WHAT IT IS USED FOR Niopam is a special dye (or contrast agent) which blocks X-rays because it contains iodine. Niopam works by helping your doctor to see the internal body structures on an X-ray picture. Your doctor has prescribed Niopam to help view the blood vessels, kidney, urinary tract or bladder using X-rays. This medicine is for diagnostic use only. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN NIOPAM YOU SHOULD NOT BE GIVEN NIOPAM IF YOU: • Are allergic to Iopamidol, or any other ingredients of this medicine (listed in Section 6) TAKE SPECIAL CARE WITH NIOPAM AND TELL YOUR DOCTOR IF YOU HAVE ANY OF THE FOLLOWING CONDITIONS: • A history of allergy or asthma • Diabetes • Heart problems • High blood pressure in the lungs • Kidney or liver problems • Over-active thyroid gland (this is particularly important in newborn babies) • A history of epilepsy • Myelomatosis (Cancer of the plasma cells in the blood) • Severe systemic disease (a disease affecting more than one part or organ of the body) ì • Sickle ce Lestu allt skjalið
Health Products Regulatory Authority 13 March 2023 CRN00DGL8 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Niopam 370, Solution for Injection, glass bottles 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The solution contains 75.53% w/v Iopamidol, equivalent to 370 mg Iodine/ml. Each ml contains 755.3mg Iopamidol. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Injection. A clear aqueous solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS X‑ray contrast medium for use in angiography, left ventriculography and coronary arteriography and urography. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Method of administration Intraventricular Intra-arterial Intravenous. Posology NIOPAM 370 : DOSAGE SCHEDULE Procedure Dosage Peripheral arteriography Venography Adults 10 - 50ml* Children * * Adults 20 - 50ml Children * * Angiocardiography and left ventriculography Adults 30 - 80ml Children * * Coronary arteriography Adults 4 - 8ml per artery Aortography - retrograde Adults 30 - 80ml Children * * Selective renal arteriography Health Products Regulatory Authority 13 March 2023 CRN00DGL8 Page 2 of 9 Hepatic Coeliac Superior Mesenteric Inferior Mesenteric Adults 30 - 70ml 40 - 70ml 25 - 70ml 5 - 30ml Children * * Selective visceral angiography Intravenous Injection Left ventriculography Selective Coronary Arteriography by Intra-Arterial DSA Adults 30 - 70ml Children 40 - 70ml Adults 25 - 70ml Children 5 - 30ml Adults 2 - 5ml Intravenous Urography Adults 40 - 80ml In severe renal failure the usual high dose methods should be employed (up to 1.5ml/kg) Children 1 - 2.5ml/kg or * * * Repeat as necessary * * According to body size and age Elderly: Dosage as for adults. The dosage must be adapted to the examination, the age, body weight, cardiac output, renal function, general condition of the patient and the technique used. Usually the same iodine concentration and volume are used with other iodinated x-ray contrast in current use. As with all contrast media, th Lestu allt skjalið